The long road to universal antiretroviral treatment coverage in South Africa

Future Virology

Volumn 6, Issue 7, 2011, Pages 801-812

  Wouters, Edwin ^a,b   Heunis, Christo ^b   Michielsen, Joris ^a   Baron Van Loon, Francis ^a   Meulemans, Herman ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

antiretroviral treatment; HIV AIDS; public sector ART program; South Africa

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; FOLLOW UP; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SOUTH AFRICA; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 79960418123     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.11.56     Document Type: Review

References (90)

1. Abdool Karim SS, Churchyard GJ, Abdool Karim Q, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet 374(9693), 921-933 (2009).
2. Rehle TM, Hallet TB, Shisana O et al. A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS one 5(6), e11094 (2010).
3. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 354(9193), 1896-1900 (1999).
4. Walsh D, Downe S. Appraising the quality of qualitative research. Midwifery 22(2), 108-119 (2006). (Pubitemid 43728524)
5. Mckee M, Britton A. Conducting a literature review on the effectiveness of health care interventions. Health Policy Plan 12(3), 262-267 (1997). (Pubitemid 27397178)
6. Oxman AD. Systematic reviews: checklists for review articles. BMJ 309(6955), 648-651 (1994). (Pubitemid 24281192)
7. Popay J, Baldwin S, Arai L et al. Narrative synthesis in systematic reviews. Methods Briefing 4, (2003).
8. Mee P, Fielding K, Charalambous S, Churchyard GJ, Grant AD. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS 22(15), 1971-1977 (2008).
9. Wouters E, Van Rensburg HCJ, Van Loon F, Meulemans H. State of the ART programme: clinical effectiveness and physical and emotional quality-of-life improvements in the Free State Province, South Africa. AIDS Care 21(11), 1401-1411 (2009).
10. Boulle A, Van Cutsem G, Hilderbrand K et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. 24(4), 563-572 (2010).
11. Hoffmann CJ, Fielding Kl, Charalambous S et al. Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events. AIDS 22(1), 67-74 (2008). (Pubitemid 350294879)
12. Lawn S, Myer L, Bekker LG, Wood R. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect. Dis. 6(1), 59 (2006).
13. Lawn SD, Little F, Bekker LG et al. Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS 23(3), 335-342 (2009).
14. Coetzee D, Hildebrand K, Boulle A et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 18(6), 887-895 (2004). (Pubitemid 38553709)
15. Fielding K, Charalambous S, Stenson A et al. Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study. BMC Infect. Dis. 8(1), 93 (2008).
16. Charalambous S, Innes C, Muirhead D et al. Evaluation of a workplace HIV treatment programme in South Africa. AIDS 21(Suppl. 3), S73-S78 (2007). (Pubitemid 47220514)
17. Orrell C, Bangsberg DR, Badri M, Wood R. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 17(9), 1369-1375 (2003). (Pubitemid 36819851)
18. Boulle A, Van Cutsem G, Cohen K et al. Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy. JAMA 300(5), 530-539 (2008).
19. Ford N, Reuter H, Bedelu M, Schneider H, Reuter H. Sustainability of long-term treatment in a rural district: the Lusikisiki model of decentralised HIV/AIDS care. S. Afr. Med. J. 17-22 (2006). (Pubitemid 46138596)
20. Schneider H, Coetzee D, Van Renburg D, Gilson L. Differences in antiretroviral scale up in three South African provinces: the role of implementation management. BMC Health Serv. Res. 10(Suppl. 1), S4 (2010).
21. Mutevedzi PC, Lessells RJ, Heller T, Bärnighausen T, Cooke GS, Newell ML. Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull. WHO 8(8), 593-600 (2010).
22. Barth RE, Schim Van Der Loeff MF, Schuurman R, Hoepelman AIM, Wensing AMJ. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Lancet Infect. Dis. 10, 155-166 (2010).
23. Barth Re, Van Der Meer JTM, Hoepelman AIM et al. Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. Eur. J. Clin. Microbiol. Infect. Dis. 27(10), 977-984 (2008).
24. May M, Boulle A, Phiri S et al. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet 376(9739), 449-457 (2010).
25. Reddi A, Leeper S, Grobler A et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatrics 7(1), 13 (2007).
26. Wouters E, Heunis C, Ponnet K et al. Who is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementation. BMC Public Health 10(1), 387 (2010).
27. Cornell M, Myer L, Kaplan R, Bekker LG, Wood R. The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Trop. Med. Int. Health 14(7), 722-731 (2009).
28. Fairall LR, Bachmann MO, Louwagie GMC et al. Effectiveness of antiretroviral treatment in a South African program. Arch. Intern. Med. 168(1), 86-93 (2008).
29. Badri M, Lawn SD, Wood R. Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting. BMC Infect. Dis. DOI: 10.1186/1471-2334-8-89 (2008). (Pubitemid 352025050)
30. Bekker LG, Myer L, Orrell C, Lawn S, Wood R. Rapid scale-up of community-based HIV treatment service. Programme performance over 3 consecutive years in Guguletu, South Africa. S. Afr. Med. J. 96(4), 315-320 (2006).
31. Bedelu M, Ford N, Hildebrand K, Reuter H. Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. The J. Infect. Dis. 196(Suppl. 3), S464-S468 (2007). (Pubitemid 351417239)
32. Nachega JB, Stein DM, Lehmann U et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res. Hum. Retroviruses 20(10), 1053-1056 (2004). (Pubitemid 39392009)
33. Ford N, Darder M, Spelman T, Maclean E, Mills E, Boulle A. Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohort. PLoS one 5(5), E10460 (2010).
34. Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann. Intern. Med. 146(8), 564-573 (2007). (Pubitemid 351650537)
35. Macpherson P, Moshabela M, Martinson NA, Pronyk PM. Mortality and loss to follow-up among HAART initiators in rural South Africa. Trans. R. Soc. Trop. Med. Hyg. 103(6), 588-593 (2009).
36. Sterne JA, Hernán MA, Ledergerber B et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 366(9483), 346-347 (2005).
37. Achmat Z, Simcock J. Combining prevention, treatment and care: lessons from South Africa. AIDS 21(Suppl. 4), S11-S20 (2007). (Pubitemid 47051745)
38. Barker PM, McCannon CJ, Mehta N et al. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization. J. Infect. Dis. 196(Suppl. 3), S457-S463 (2007). (Pubitemid 351419183)
39. Bärnighausen T, Bloom DE, Humair S. Human resources for treating HIV/AIDS: needs, capacities, and gaps. Aids Patient Care STDS 21(11), 799-812 (2007).
40. Chopra M, Daviaud E, Pattinson R, Fonn S, Lawn JE. Saving the lives of South Africa's mothers, babies, and children: can the health system deliver? Lancet 374(9692), 835-846 (2009).
41. Chopra M, Lawn JE, Sanders D et al. Achieving the health millennium development goals for South Africa: challenges and priorities. Lancet 374(9694), 1023-1031 (2009).
42. Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 367(9514), 926-937 (2006).
43. Dong K, Thabethe Z, Hurtado R et al. Challenges to the success of HIV and tuberculosis care and treatment in the public health Sector in South Africa. J. Infect. Dis. 196(Suppl. 3), S491-S496 (2007). (Pubitemid 351417243)
44. El-Sadr WM, Abrams EJ. Scale-up of HIV care and treatment: can it transform healthcare services in resource-limited settings? AIDS 21, S65-S70 (2007). (Pubitemid 350294909)
45. Fatti G, Grimwood A, Bock P. Better antiretroviral therapy outcomes at primary healthcare facilities: an evaluation of three tiers of ART services in four South African provinces. PLoS one 5(9), E12888 (2010).
46. Friedland G, Harries A, Coetzee D. Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies. J. Infect. Dis. 196(Suppl. 1), S114-S123 (2007). (Pubitemid 47206090)
47. Kranzer K, Zeinecker J, Ginsberg P et al. Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS ONE 5(11), e13801 (2010).
48. Meyers T, Moultrie H, Naidoo K, Cotton M, Eley B, Sherman G. Challenges to pediatric HIV care and treatment in South Africa. J. Infect. Dis. 196(Suppl. 3), S474-S481 (2007). (Pubitemid 351417241)
49. Nakanjako D, Colebunders R, Coutnhi AG, Kamya MR. Strategies to optimize HIV treatment outcomes in resource-limited settings. AIDS Rev. 11(4), 179-189 (2009).
50. Ojikutu B, Jack C, Ramjee G. Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles. J. Infect. Dis. 196(Suppl. 3), S523-S527 (2007). (Pubitemid 351417249)
51. Rajaraman D, Palmer N. Changing roles and responses of health care workers in HIV treatment and care. Trop. Med. Int. Health 13(11), 1357-1363 (2008). (Pubitemid 352678090)
52. Schneider H, Coetzee D. Strengthening the health system and ensuring equity in the widescale implementation of an antiretroviral therapy programme in South Africa. S. Afr. Med. J. 93(10), 772-773 (2003). (Pubitemid 37428531)
53. Schneider H, Coetzee D, Van Rensburg D, Gilson L. Differences in antiretroviral scale up in three South African provinces: the role of implementation management. BMC Health Serv. Res. 10(Suppl. 1), S4 (2010).
54. Stewart R, Loveday M. The operational plan: implementation of the antiretroviral therapy component. In:South African Health Review 2005. Ijumba P, Barron P (Eds).Health Systems Trust, Durban, South Africa (2005).
55. Tsai AC, Chopra M, Pronyk PM, Martinson NA. Socioeconomic disparities in access to HIV/AIDS treatment programs in resource-limited settings. AIDS Care 21(1), 59-63 (2009).
56. Van Rensburg HCJ, Steyn F, Schneider H, Loffstadt L. Human resource development and antiretroviral treatment in free state province, South Africa. Hum. Resour. Health 6(15), 31 (2008).
57. Walensky RP, Wood R, Weinstein MC et al. Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. J. Infect. Dis. 197(9), 1324-1332 (2008). (Pubitemid 351632764)
58. Wouters E, Van Rensburg D, Meulemans H. The national strategic plan of South Africa: what are the prospects of success after the repeated failure of previous AIDS policy? Health Policy Plan 25(3), 171-185 (2010).
59. Schneider H, Lehmann U. Lay health workers and HIV programmes: implications for health systems. AIDS Care 22(Suppl. A), 60-67 (2010).
60. Buse K, Waxman A. Public-private partnerships: a strategy for WHO. Bull. WHO 79, 748-754 (2001).
61. Adam MA, Johnson LF. Estimation of adult antiretroviral treatment coverage in South Africa. S. Afr. Med. J. 99(9), 661-667 (2009)
62. Ooms G. The right to health and the sustainability of healthcare: why a new global health aid paradigm is needed. Faculty Med. Health Sci. Doctoral thesis, 306 (2007).
63. Bartlett JA, Shao JF. Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries. Lancet Infect. Dis. 9(10), 637-649 (2009).
64. Cornell M, Grimsrud A, Fairall L et al. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS 24(14), 2263-2270 (2010).
65. Dahab M, Charalambous S, Hamilton R et al. "That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health 8(1), 63 (2008).
66. Myer L, El-Sadr W. Expanding access to antiretroviral therapy through the public sector - the challenge of retaining patients in long-term primary care. S. Afr. Med. J. 94(4), 273-274 (2004). (Pubitemid 38585219)
67. Nglazi MD, Lawn SD, Kaplan R et al. Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa. J. Acquir. Immune Defic. Syndr. 56(1), E1-E8 (2011).
68. Schneider H, Hlophe H, Van Rensburg HCJ. Community health workers and the response to HIV/AIDS in South Africa: tensions and prospects. Health Policy Plan 23(3), 179-187 (2008).
69. Stein J, Lewin S, Fairall L. Hope is the pillar of the universe: health-care providers' experiences of delivering anti-retroviral therapy in primary health-care clinics in the free state province of South Africa. Soc. Sci. Med. 64(4), 954-964 (2006). (Pubitemid 46080566)
70. Van Damme W, Kober K, Kegels G. Scaling-up antiretroviral treatment in Southern African countries with human resource shortage: how will health systems adapt? Soc. Sci. Med. 66(10), 2108-2121 (2008). (Pubitemid 351509687)
71. Wagner G, Ryan G, Taylor S. Formative Evaluation of antiretroviral therapy scale-up efficiency in sub-Saharan Africa. Aids Patient Care STDS 21(11), 871-888 (2007).
72. Gifford AL, Groessl EJ. Chronic disease self-management and adherence to HIV medications. J. Acquir. Immune Defic. Syndr. 31(3), S163-S166 (2002). (Pubitemid 35453580)
73. Moatti JP, Spire B, Kazatchkine M. Drug resistance and adherence to HIV/AIDS antiretroviral treatment: against a double standard between the north and the south. AIDS 18(Suppl. 3), S55-S61 (2004). (Pubitemid 39037461)
74. Bangsberg DR, Hecht FM, Charlebois ED et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 14(4), 357-366 (2000). (Pubitemid 30182431)
75. Mocroft A, Vella S, Benfield TL et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA study group. Lancet (352), 1725-1730 (1998). (Pubitemid 28534954)
76. Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, Goemaere E. Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS 18(Suppl. 3), S27-S31 (2004). (Pubitemid 39037456)
77. Wouters E, Van Damme W, Van Loon F, Van Rensburg D, Meulemans H. Public-sector ART in the free state province, South Africa: Community support as an important determinant of outcome. Soc. Sci. Med. 69(8), 1177-1185 (2009).
78. Wouters E, Van Loon F, Van Rensburg HCJ, Meulemans H. Community support and disclosure of serostatus to family members by public-sector ART patients in the free state province of South Africa. Aids Patient Care STDS 23(5), 357-364 (2009).
79. Rosen S, Long L, Sanne I. The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Trop. Med. Int. Health 13(8), 1005-1015 (2008).
80. Hecht R, Bollinger L, Stover J et al. Critical choices in financing the response to the global HIV/AIDS pandemic. Health Aff. (Millwood) 28(6), 1591-1605 (2009).
81. Cleary S, Mooney G, Mcintyre D. Equity and efficiency in HIV-treatment in South Africa: the contribution of mathematical programming to priority setting. Health Econ. 19(10), 1166-1180 (2010).
82. Kober K, Van Damme W. Scaling up access to antiretroviral treatment in southern Africa: who will do the job? Lancet 329, 103-107 (2004). (Pubitemid 38968632)
83. Tobi P, George G, Schmidt E, Renton A. Antiretroviral treatment and the health workforce in South Africa: how have ART workers been affected by scaling-up? Trop. Med. Int. Health 13(12), 1452-1458 (2008).
84. Soni A, Gupta R. Bridging the resource gap: improving value for money in HIV/AIDS treatment. Health Aff. (Millwood) 28(6), 1617-1628 (2009).
85. Day C, Gray A. Health and related indicators. In:South African Health Review 2008 , Barron P, Roma-Reardon J (Eds.) Health Systems Trust, Durban, South Africa 239-396 (2008).
86. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4(10), e298 (2007).
87. Van Rensburg HCJ: Health and Health Care in South Africa. van Schaik Publishers, Pretoria, South Africa (2004).
88. Lehmann U, Van Damme W, Barten F, Sanders D. Task shifting: the answer to the human resources crisis in Africa? Hum. Resour. Health 7(1), 1-4 (2009).
89. Wouters E, Van Damme W, Van Rensburg D, Meulemans H. Impact of baseline health and community support on antiretroviral treatment outcomes in HIV patients in South Africa. AIDS 22(18), 2545-2549 (2008).
90. Kigozi NG, Heunis JC, Van Den Berg HS. Tuberculosis patients' perspectives on HIV counselling by lay counsellors vis-a-vis nurses: an exploratory study in two districts of the Free State Province, South Africa. Afr. J. Nurs. Midwif. DOI: 10.1186/1472-6963- 11-110 (2011) (In Press).